Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-07

FDA Approved: FAMOTIDINE — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved Ascend Laboratories' original application for famotidine, establishing a new generic entry for the acid-reducing medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famotidine (generic) (famotidine)
  • Pepcid (famotidine)

Snippet

ORIG AP for FAMOTIDINE (FAMOTIDINE)